id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S14440 R57298 |
Wang - HK cohort, 2021 | Gestational diabetes mellitus (GDM; using ICD code or a clinician reported GDM) | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, sick | Adjustment: Yes | 0.82 [0.28;2.45] | -/- 40/340 | - | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S14441 R57299 |
Wang - UK cohort, 2021 | Gestational diabetes mellitus (GDM; using Read Code classification or a recorded fasting plasma glucose level of 5.6 mmol/l or above or a 2-h plasma glucose level of 7.8 mmol/l or above) | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, sick | Adjustment: Yes | 1.53 [0.33;6.95] | -/- 40/1,577 | - | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3192 R5109 |
Park, 2018 | Gestational diabetes | at least 1st trimester | retrospective cohort (claims database) | unexposed, sick | Adjustment: Yes | 1.61 [1.13;2.29] | 46/384 49/1,041 | 95 | 384 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2457 R3134 |
Vigod, 2015 | Gestational diabetes | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, sick | Adjustment: No | 1.31 [0.71;2.45] C | 13/166 62/1,021 | 75 | 166 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3850 R8189 |
Boden (Control exposed to other antipsyhcotics), 2012 | Gestational diabetes | during pregnancy (anytime or not specified) | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: No |
0.93 [0.37;2.33] C excluded (control group) |
7/169 15/338 | 22 | 169 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2408 R3075 |
Boden (Control unexposed, NOS), 2012 | Gestational diabetes | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes | 1.94 [0.97;3.91] | 7/169 5,970/357,696 | 5,977 | 169 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 5 studies | 1.53 [1.17;2.00] | 6,147 | 719 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Control unexposed, NOS;
Asymetry test p-value = 0.4607 (by Egger's regression)
slope=0.5920 (0.2239); intercept=-0.6184 (0.7327); t=0.8439; p=0.4607
excluded 3850